Cargando…
Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction
Type-2 Familial Partial Lipodystrophy (FPLD2), a rare lipodystrophy caused by LMNA mutations, is characterized by a loss of subcutaneous fat from the trunk and limbs and excess accumulation of adipose tissue in the neck and face. Several studies have reported that the mineralocorticoid receptor (MR)...
Autores principales: | Schena, Elisa, Mattioli, Elisabetta, Peres, Chiara, Zanotti, Laura, Morselli, Paolo, Iozzo, Patricia, Guzzardi, Maria Angela, Bernardini, Chiara, Forni, Monica, Nesci, Salvatore, Caprio, Massimiliano, Cecchetti, Carolina, Pagotto, Uberto, Gabusi, Elena, Cattini, Luca, Lisignoli, Gina, Blalock, William, Gambineri, Alessandra, Lattanzi, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670260/ https://www.ncbi.nlm.nih.gov/pubmed/37998321 http://dx.doi.org/10.3390/cells12222586 |
Ejemplares similares
-
Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning
por: Pellegrini, Camilla, et al.
Publicado: (2019) -
Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy
por: Algieri, Cristina, et al.
Publicado: (2022) -
Case Report: An Atypical Form of Familial Partial Lipodystrophy Type 2 Due to Mutation in the Rod Domain of Lamin A/C
por: Cecchetti, Carolina, et al.
Publicado: (2021) -
Polycystic ovary syndrome in familial partial lipodystrophy type 2 (FPLD2): basic and clinical aspects
por: Gambineri, Alessandra, et al.
Publicado: (2018) -
Is it possible to achieve an acceptable disease control by dietary therapy alone in Berardinelli Seip type 1? Experience from a case report
por: Cecchetti, Carolina, et al.
Publicado: (2023)